BioSpace News Archive

Aitia, the leader in the application of Causal AI and Digital Twins to discover and develop new drugs, announced today that data from its neurodegenerative disorders Digital Twins, including Alzheimer’s Disease (AD) and Parkinson Disease (PD), will be presented at the upcoming Society of Neuroscience (SfN) Conference, being held from November 11-15, 2023 in Washington, D.C.

Surrozen, Inc., a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, provided third quarter 2023 financial results and business updates.

TFF Pharmaceuticals, Inc. announced the publication of research demonstrating the feasibility of intranasal delivery of monoclonal antibodies using the Company’s proprietary Thin Film Freezing technology.

Bionano Genomics, Inc. reported financial results for the third quarter ended September 30, 2023.

Acutus Medical, Inc. reported results for the third quarter of 2023.

MaxCyte, Inc. announced financial results for the third quarter ended September 30, 2023.

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today reported financial results for the third quarter ended September 30, 2023 and reviewed recent business highlights.

Better Therapeutics, Inc. today announced it will release its third quarter 2023 financial results before the market opens on Thursday, November 09, 2023.

ImmPACT Bio USA , Inc. today announced it has been named on the BioSpace 2024 Best Places to Work small employer list.